REBECCA TOKARSKI: Open Payments
NPI 1003335282 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$453 in 10 payments from 6 companies in 2025. Trend: 2023 $124 · 2024 $620 · 2025 $453
Food & beverage: $453
| Company | Payments | Amount |
|---|---|---|
| Adaptive Biotechnologies Corporation | 4 | $137 |
| E.R. Squibb & Sons, L.L.C. | 1 | $117 |
| Merck Sharp & Dohme LLC | 1 | $116 |
| Alnylam Pharmaceuticals Inc. | 2 | $46 |
| Genmab U.S., Inc. | 1 | $20 |
| Celgene Corporation | 1 | $17 |
Products named: clonoSEQ, BREYANZI, PREVYMIS, AMVUTTRA, Epkinly, REBLOZYL.
Industry payments across OH — which companies pay providers there.
